4.6 Article

Mitochondrial Function and Microbial Metabolites as Central Regulators of Intestinal Immune Responses and Cancer

Journal

FRONTIERS IN MICROBIOLOGY
Volume 13, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fmicb.2022.919424

Keywords

mitochondria; microbiota; metabolites; inflammation; cancer

Categories

Funding

  1. German Research Foundation (DFG) [SO1141/10-1]
  2. Research Training Group Genes, Environment and Inflammation [RTG1743]
  3. Research Unit FOR5042 miTarget The Microbiome as a Target in Inflammatory Bowel Diseases (project P5)
  4. Collaborative Research Centre CRC1182 Origin and Function of Metaorganisms (project C2)
  5. Cluster of Excellence EXS2167 Precision Medicine in Chronic Inflammation
  6. medical faculty of Kiel University [K126408]

Ask authors/readers for more resources

Energy and anabolic metabolism are crucial for cellular homeostasis and also play a role in immune responses and cancer development. Mitochondria play a prominent role in these processes, reacting to internal and external cues, including those from the microbiota. Dysbiosis of the microbiota has been associated with diseases, and targeting the microbiota-mitochondria interactions may be a promising therapeutic approach for inflammation and cancer.
Energy and anabolic metabolism are essential for normal cellular homeostasis but also play an important role in regulating immune responses and cancer development as active immune and cancer cells show an altered metabolic profile. Mitochondria take a prominent position in these metabolic reactions. First, most key energetic reactions take place within or in conjunction with mitochondria. Second, mitochondria react to internal cues from within the cell but also to external cues originating from the microbiota, a vast diversity of associated microorganisms. The impact of the microbiota on host physiology has been largely investigated in the last decade revealing that the microbiota contributes to the extraction of calories from the diet, energy metabolism, maturation of the immune system and cellular differentiation. Thus, changes in the microbiota termed dysbiosis have been associated with disease development including metabolic diseases, inflammation and cancer. Targeting the microbiota to modulate interactions with the mitochondria and cellular metabolism to delay or inhibit disease development and pathogenesis appears an attractive therapeutic approach. Here, we summarize recent advances in developing the therapeutic potential of microbiota-mitochondria interactions for inflammation and cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available